First and foremost & in the interest of transparency. I now own shares in Concepta: AIM CPT.
Concepta listed in 2016. They’re a small bio/healthcare company. You can read their listing RNS HERE
Currently they have 4 products on the market. Pregnancy Test kit, Ovulation Test, Fertility app and the myLotus Monitor. They were heavily tipped a long time ago by Tom Winnifrith (at 15pish)on Hot Stock Rockets and as recently as Sept’ 2020 by Steve Moore. However what both failed to foresee is that todays RNS is a potential game changer from the recently installed head honcho Penny McCormick (CEO) “Our focus now is moving immediately to the development of our next generation MYLO®connected AI platform, rather than investing in further development of our MYLO® tracker” and “we are confident that we have the opportunity and expertise to deliver a globally leading product to a rapidly growing home-testing diagnostic space”
The key to the above is this line: ‘Rapidly growing home testing diagnostic space’. Todays RNS confirms that that space now potentially includes Covid 19 testing. Read Here They’re a UK based healthcare company run by consummate professionals who know their science.
Any news whatsoever of a Covid testing product or a tie up regards any other company involved in the Covid space will see the Concepta share price rise dramatically.
Well worth a small punt